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A Modified Collagen Dressing 
Induces Transition of Inflammatory 
to Reparative Phenotype of Wound 
Macrophages
Amitava Das1,2, Motaz Abas2, Nirupam Biswas1,2, Pradipta Banerjee1,2, Nandini Ghosh1,2, 
Atul Rawat1, Savita Khanna1,2, Sashwati Roy1,2 & Chandan K. Sen1,2
Collagen containing wound-care dressings are extensively used. However, the mechanism of action 
of these dressings remain unclear. Earlier studies utilizing a modified collagen gel (MCG) dressing 
demonstrated improved vascularization of ischemic wounds and better healing outcomes. Wound 
macrophages are pivotal in facilitating wound angiogenesis and timely healing. The current study 
was designed to investigate the effect of MCG on wound macrophage phenotype and function. MCG 
augmented recruitment of macrophage at the wound-site, attenuated pro-inflammatory and promoted 
anti-inflammatory macrophage polarization. Additionally, MCG increased anti-inflammatory IL-10, IL-4 
and pro-angiogenic VEGF production, indicating a direct role of MCG in resolving wound inflammation 
and improving angiogenesis. At the wound-site, impairment in clearance of apoptotic cell bioburden 
enables chronic inflammation. Engulfment of apoptotic cells by macrophages (efferocytosis) resolves 
inflammation via a miR-21-PDCD4-IL-10 pathway. MCG-treated wound macrophages exhibited a 
significantly bolstered efferocytosis index. Such favorable outcome significantly induced miR-21 
expression. MCG-mediated IL-10 production was dampened under conditions of miR-21 knockdown 
pointing towards miR-21 as a causative factor. Pharmacological inhibition of JNK attenuated 
IL-10 production by MCG, implicating miR-21-JNK pathway in MCG-mediated IL-10 production by 
macrophages. This work provides direct evidence demonstrating that a collagen-based wound-care 
dressing may influence wound macrophage function and therefore modify wound inflammation 
outcomes.
Non-resolving persistent inflammation contributes to wound chronicity1,2. Inflammation is required to set the 
process of wound healing in motion3. However, it is important to resolve such inflammation in a timely manner 
to achieve healing4. Wound inflammation is subject to sophisticated regulation by a number of key factors includ-
ing the environment of the wound which is rich in extracellular matrix (ECM)5. Increased expression of matrix 
metalloproteinases (MMPs), enzymes that degrade ECM proteins, is a hallmark of persistent inflammation6. 
Following tissue injury and degradation of ECM, matrix fragments elicit cell signaling aimed at modulating 
inflammation and implementing the healing response7. Collagen peptides arising from ECM breakdown are 
known to influence the process of inflammation8,9.
Collagen is biodegradable and possess weak antigenic properties10. Collagen-based dressings are extensively 
used in wound care11,12. These dressings are biocompatible, safe and easily applicable and can be combined with 
other modalities of care13. Treatment of wounds with collagen promoted hemostasis and chemotaxis14. Modified 
collagen gel (MCG) is a bovine collagen based wound dressing. Using preclinical porcine models of excisional and 
ischemic wounds we have observed that MCG is effective in resolving inflammation and improving angiogenesis 
in these wounds15,16. Highly plastic wound-site macrophages play a pivotal role in tissue repair17–20. Depending 
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upon micro-environmental conditions, macrophages possess a wide range of functions which are modulated 
through the release of several factors21. Successful and timely resolution of inflammation involves switching of 
macrophages from an inflammatory (mφinf) to a reparative (mφheal) phenotype. In the current work, we sought 
to evaluate the effect of MCG on macrophage function and polarization in the context of wound inflammation.
Results
MCG augmented recruitment of macrophage to the wound site and attenuated pro-inflamma-
tory macrophage polarization. To determine whether MCG treatment affect the macrophage abundance 
at the wound-site during inflammatory phases, poly vinyl alcohol (PVA) sponges soaked in MCG stock solution 
were implanted subcutaneously in mice. Wound inflammatory cells were harvested from PVA sponges on day 3 
and day 7 post-wounding (PW), stained with FITC conjugated F4/80, a murine macrophage marker and analyzed 
using flow cytometry. MCG treated wound cells displayed significantly higher abundance of F4/80+ macrophages 
as compared to those from untreated wounds at both time points (Fig. 1). To determine whether MCG played 
a role in macrophage polarization, wound macrophages isolated from PVA sponges (CD11b+) were stained 
with F4/80-FITC and PE-conjugated mφinf/mφheal surface markers. The double positive cells were analyzed for 
mφinf surface markers CD40, CD11c, CD16/32 CD284, and mφheal surface markers CD206 and CD23 (Fig. 2A). 
Significantly lower expression of all mφinf surface markers and higher expression of mφheal surface markers were 
observed in mφ exposed to MCG on day 3 and day 7 post-implantation respectively, indicating a shift in wound 
macrophage polarization to an anti-inflammatory, reparative mφheal phenotype in response to MCG (Fig. 2 and 
Supplementary Fig. S1).
Figure 1. MCG increased macrophage infiltration at wound-site. Wound inflammatory cells were harvested 
from MCG treated PVA sponges on day 3 (A,B) and day 7 (C,D) post-implantation from C57BL/6 mice. 
(A,C) The cells were immunostained with F4/80 and subjected to flow cytometry analysis. (B,D) F4/80+ cells 
were quantified from the gated cell populations at both time points. Data are mean ± SEM (n = 3); *p < 0.05 
compared to cells harvested from untreated PVA sponges.
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Upregulation of anti-inflammatory IL-10 and VEGF in MCG-treated wound cells and cultured 
macrophages. Anti-inflammatory mφheal macrophages produce copious amount of Interleukin-10 (IL-10), 
Interleukin-4 (IL-4) and Vascular Endothelial Growth Factor (VEGF) which helps in resolution of inflammation22–24 
and promotes angiogenesis25–27. To determine whether MCG promoted an anti-inflammatory milieu at the 
wound-site, these anti-inflammatory cytokines were quantified from conditioned media of wound inflamma-
tory cells derived from MCG-treated wounds. IL-10 protein was strongly upregulated in MCG-treated wound 
inflammatory cells (Fig. 3A). When studied in individual wound cell population, MCG was observed to induce 
IL-10 (Fig. 3B,C) and pro-angiogenic VEGF (Fig. 3D) in wound macrophages. To test a direct effect of MCG on 
macrophage IL-10, IL-4 and VEGF production, wound macrophages and differentiated THP-1 derived mac-
rophages were utilized. Measurement of protein by ELISA demonstrated significant induction of IL-10, IL-4 
and VEGF protein following treatment with MCG in both wound macrophages and differentiated THP-1 cells 
(Supplementary Fig. S2A–C and Fig. 4).
MCG induced the efferocytosis-JNK-miR-21 pathway. We have reported that engulfment of apop-
totic cells by macrophages (aka, efferocytosis) is a signaling cue that drives polarization to anti-inflammatory 
mφheal phenotype via miR-21- programmed cell death 4 (PDCD4)-IL-10 pathway18. Thus, the effect of 
MCG treatment on macrophage efferocytosis activity was determined. A significantly elevated efferocytosis 
index was noted in macrophages treated with MCG as compared to matched untreated controls (Fig. 5A,B). 
Successful efferocytosis is known to induce miR-21 expression, which via phosphatase and tensin homolog 
(PTEN) and PDCD4 silencing, switches macrophage to an anti-inflammatory mφheal phenotype18. In this 
work, MCG-induced efferocytosis was associated with elevated miR-21 expression (Fig. 5C). Interestingly, 
MCG-induced IL-10 expression was blunted under conditions of miR-21 knockdown (Fig. 5D, Supplementary 
Figure 2. MCG attenuated mφinf and promoted mφheal polarization of wound macrophage in the inflammatory 
phase. d3 wound macrophages (CD11b+) were harvested from MCG treated PVA sponges subcutaneously 
implanted in C57BL/6 mice. The cells were immune-stained using PE conjugated mφinf/mφheal markers and 
co-immunostained with FITC conjugated F4/80 and subjected to flow cytometry analysis. (A) Gating strategy 
in which the mφinf/mφheal markers were determined in double positive cells (quadrant Q2). (B–G) Quantitative 
analysis of the expression (mean fluorescence intensity, MFI) is expressed as bar graphs for individual mφinf/mφheal 
markers. Data are mean ± SEM (n = 6); *p < 0.05 compared to cells harvested from untreated PVA sponges.
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Fig. S3A). This line of evidence recognizes miR-21 as a mechanism implicated in MCG-induced IL-10 pro-
duction by macrophages. We have previously reported that pharmacological inhibition of c-Jun N-terminal 
kinase (JNK) or knockdown of cellular c-Jun resulted in significant downregulation of inducible IL-10 pro-
tein expression, demonstrating a direct role of c-Jun and JNK in LPS-induced IL-10 expression in human 
monocyte-derived macrophages18. The JNK inhibitor (420119 JNK Inhibitor II) significantly inhibited 
MCG-induced IL-10 production (Fig. 5E). To further determine if MCG → miR-21 → IL-10 induction is via 
JNK pathway, THP-1 cells were transfected with miRIDIAN hsa–miR-21 mimic to increase cellular miR-21 
abundance (Supplementary Fig. S3B) followed by knockdown of c-Jun using siRNA(Supplementary Fig. S3C) 
and treatment with MCG. Knocking down c-Jun under these conditions resulted in abrogation of MCG-induced 
IL-10 even in high miR-21 conditions suggesting a central role of cJun-JNK pathway in MCG → miR21 induced 
IL-10 production (Fig. 5F). Finally, a summary of the proposed pathway implicated in anti-inflammatory effect 
of MCG via IL-10 production has been presented (Fig. 6).
Discussion
The microenvironment of tissue injury is characterized by the infiltration of visiting immune cells in a situa-
tion where collagen and its fragmented products are in abundance. Collagen and its degradation products have 
been recognized to induce signal transduction which in turn modulates several physiological functions like cell 
adhesion and migration, hemostasis and immune function28,29. Interestingly, a clostridial collagenase ointment 
Figure 3. MCG induced IL-10 & VEGF release by murine wound cells. Wound inflammatory cells on 
d3 were harvested from MCG treated PVA sponges subcutaneously implanted in C57BL/6 mice. The 
wound inflammatory cells were harvested from the sponges, and subjected to ELISA for (A) IL-10 protein 
expression analysis. (B) d3 wound macrophages (CD11b+) were harvested from MCG treated PVA sponges 
subcutaneously implanted in C57BL/6 mice and subjected to ELISA for IL-10 protein expression. (C,D) d7 
wound macrophages (CD11b+) were harvested from MCG treated PVA sponges subcutaneously implanted in 
C57BL/6 mice and subjected to ELISA for (C) IL-10 and (D) VEGF protein expression. Data are mean ± SEM 
(n = 5–6); *p < 0.05 compared to wound cells/macrophages harvested from untreated PVA sponges.
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resolves inflammation through a PGE2-EP4-STAT6 signaling pathway30. Collagen degraded to its peptide com-
ponents is readily phagocytosed by macrophages at the wound-site31,32. Whether such engulfment of collagen 
peptides induces any cellular signaling in macrophages remains unknown. This report provides maiden evidence 
demonstrating that a modified collagen based wound dressing (MCG), generated by tryptic digestion and com-
posed of short and long chain peptides of collagen, induces mφheal-like polarization in wound macrophages, 
including production of copious amounts of anti-inflammatory and pro-angiogenic response by these cells.
Circulating monocytes recruited to the wound tissue differentiate to macrophages that are critical in orches-
trating the inflammatory and subsequent repair process at the wound-site33–35. Consistent with findings of the 
current study, an increased macrophage infiltration in excisional wounds treated with modified collagen gel in a 
porcine model was also noted suggesting that MCG possess a macrophage chemoattractant property16. LC-MS/
MS studies from our laboratory have demonstrated that MCG is composed of long and short chain peptides 
derived from collagen16. Synthetic polypeptides such as pentameric (Pro-Pro-Gly)5 form as well as peptides of 
bovine collagen digested by collagenase are known to display potent chemoattractant activity for rat alveolar 
macrophages36 and human monocytes37. The exact mechanism of collagen peptide mediated macrophage che-
moattractant function remains unclear. It is plausible that collagen peptides promote production of Monocyte 
Chemoattractant Protein-1 (MCP-1), a potent macrophage chemo-attractant, thereby increasing the macrophage 
infiltration.
Once extravasated, macrophage phenotype and function is guided by environmental cues18,38. At the 
wound-site, macrophages are known to serve functionally distinct roles including the classical (proinflam-
matory, mφinf) and alternative (anti-inflammatory, prohealing, mφheal) activation states35,38–40. While the 
pro-inflammatory mφinf macrophages are responsible for the clearing of infectious agents, the mφheal macrophages 
are more reparative in nature and enable timely resolution of inflammation and promote angiogenesis15,34,41. 
Chronic diabetic ulcers with unresolved inflammation display aberrant mφinf:mφheal macrophage ratio and an 
imbalance between pro- and anti-inflammatory environment42,43. CD40, CD16-32, CD11c and CD284 (TLR4) 
are well-established markers of mφinf macrophage polarization34,39,40,44,45. Functional wound macrophages treated 
with MCG in vivo displayed a decrease in mφinf macrophage polarization at the inflammatory phases indicative 
of a shift in the wound macrophage polarization from mφinf to mφheal. IL-10, also known as human cytokine 
synthesis inhibitory factor (CSIF)46, is a cytokine with anti-inflammatory properties47–49 while VEGF is a potent 
angiogenic factor50. MCG-induced shift in the phenotype of the wound macrophages was coupled with induction 
of IL-10 and VEGF. These findings are consistent with increased IL-10, Mannose Receptor C-Type 1 (Mrc-1) 
and C-C Motif Chemokine Receptor 2 (CCR2) expression in MCG-treated wounds as previously reported in 
a porcine model15. Following MCG treatment, increased mφheal macrophage polarization was associated with 
an increased wound angiogenesis15,16. Given that anti-inflammatory tissue mφ have been directly implicated 
in angiogenesis27,51, it is plausible that the MCG-induced mφheal polarization of macrophages promoted wound 
angiogenesis15.
Mechanism of macrophage polarization includes complex interplay of multiple signaling pathways and tran-
scription factors52. This work identified miR-21 as a major driver of MCG-induced macrophage polarization. 
Although sample size was modest, the findings were robust primarily because of consistent effect. An overload 
of apoptotic cells at the wound-site causes inflammation to persist53. We have recently underscored a major 
role of efferocytosis and microRNA-21 (miR-21) in macrophage transition from mφinf to an anti-inflammatory 
mφheal phenotype featuring increased IL-1018. Efferocytosis or successful engulfment of apoptotic cells is known 
to promote an anti-inflammatory response in macrophages54,55 including induction of miR-21 expression18. 
An impairment of efferocytosis in diabetic wounds led to unresolved inflammation19,53. miR-21 promoted 
anti-inflammatory mφheal like response in human macrophages by directly targeting phosphatase and tensin 
homolog (PTEN) and programmed cell death protein 4 (PDCD4) that subsequently inhibited NF-κB → TNF-α 
or promoted JNK → AP-1 → IL-10 production18. Blocking of JNK resulted in an attenuation of MCG-induced 
IL-10 production suggesting that the anti-inflammatory effects of MCG involves miR-21 targeting PDCD4 fol-
lowed by activation of JNK → AP-1 → IL-10 pathway18.
Figure 4. Direct MCG treatment to human cultured macrophages induces IL-10 & VEGF production. THP-1 
cells were differentiated to macrophage with PMA (20 ng/ml, 48 h). The differentiated cells were then treated 
with MCG (100 mg/ml; 72 h) (A) IL-10 (B) IL-4 and (C) VEGF protein released from THP-1 differentiated 
human macrophages measured by ELISA. Data are mean ± SEM (n = 4–5); *p < 0.05 compared to cells 
harvested from untreated THP-1 cells.
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Figure 5. MCG promotes macrophage anti-inflammatory phenotype via promoting efferocytosis-JNK-
miR-21 pathway. (A) PVA sponges were treated with MCG (2.5 g/ml), implanted subcutaneously in C57BL/6 
mice. Day 3 wound cells were harvested from the sponges and subjected to efferocytosis assay. Representative 
images showing harvested MCG-treated macrophages (green, F4/80) cultured with apoptotic thymocytes 
(red, CMTMR cell tracker). (B) Efferocytosis index of apoptotic thymocytes engulfed by macrophages, 
calculated as total number of apoptotic cells engulfed by macrophages in a field of view divided by total 
number of macrophage present in the same field of view. Data are mean ± SEM (n = 4); *p < 0.05 compared 
to control. (C) miR-21 expression in mouse inflammatory cells collected from MCG-treated sponges at day 
3 post-implantation. Data are mean ± SEM (n = 4); *p < 0.05 compared to control. (D) IL-10 production in 
miR-21-zip cells after treatment with MCG(100 mg/ml). Data are mean ± SEM (n = 3–5); *p < 0.05 compared 
with MCG untreated miR-000-zip (control) cells; †p < 0.05 compared with MCG treated miR-000–zip cells. (E) 
IL-10 production in differentiated THP-1 cells after treatment with pharmacological JNK inhibitor (420119 
JNK Inhibitor II, 20 µM) and MCG (100 mg/ml). Data are mean ± SEM (n = 4); *p < 0.05 compared with 
MCG untreated (control) cells; †p < 0.05 compared with MCG-treated and JNK inhibitor untreated cells. (F) 
IL-10 production in THP-1 cells transfected with mimic miR-21 and si-cJun followed by treatment with MCG. 
Data are mean ± SEM (n = 5); *p < 0.05 compared with mimic control + si control transfected cells; †p < 0.05 
compared with mimic miR-21 + si control transfected cells.
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Collagen based wound dressings have been widely used in effective treatment of chronic wounds11,56. Recent 
studies from our laboratory have reported improved wound macrophage function and epithelialization using 
another stabilized collagen matrix dressing12. The current understanding of the mechanisms of action of these dress-
ings include (i) serving as a substrate for high matrix metalloproteinase (MMP) in chronic wound environment; (ii) 
the chemotactic property of the collagen breakdown products for cells critical in formation of granulation tissue and 
(iii) exudate management as a result of the high absorptive property. This work identified and characterized a novel 
mechanism of action of collagen based wound dressings in modifying wound macrophage inflammatory response. 
MCG promoted an anti-inflammatory proangiogenic mφheal-like macrophage phenotype via miR-21-cJun/JNK 
mediated signaling pathway. Results of this study were obtained from the study of macrophages that were activated 
in vivo employing a standardized PVA sponge implantation model19,30,53,57. The reported observations provide a 
valuable paradigm that is ready to be tested on macrophages directly isolated from the chronic wound patients. The 
findings of this work add a new dimension to our understanding of macrophage-ECM interactions. It provides firm 
mechanistic explanation addressing the significance of collagen based wound-care dressings.
Materials and Methods
Polyvinyl alcohol (PVA) sponge implantation model. The animal studies were approved by, and 
all methods were performed in accordance with the relevant guidelines and regulations set by The Ohio State 
University’s Institutional Animal Care and Use Committee and Indiana University’s Institutional Animal Care 
and Use Committee. Circular sterile PVA sponges (8 mm diameter) were subcutaneously implanted on the back of 
8-12-week old C57BL/6 mice under anesthesia induced by isoflurane inhalation as previously described19,30,53,57. 
PVA sponges were soaked in MCG stock solution (2.5 g/ml) for overnight (16 h). Soaking PVA sponges (each 
sponge of volume ~100 mm3) resulted in each sponge getting coated with ~125 mg of MCG solution. The weight 
of sponges post-soaking was measured to ensure equal loading of the MCG solution to each sponge. PVA sponges 
containing either MCG or saline (control) were then subcutaneously inserted into each animal. MCG was 
obtained as StimulenTM gel from Southwest Technologies Inc. (North Kansas City, MO)15,16. Harvesting of the 
PVA sponges were done on day 3/day 7 post-implantation following euthanasia. All sponges were removed and 
placed in sterile saline. Repeated compression of the sponges in saline resulted in a wound cell suspension which 
was then filtered with a 70 µm nylon cell strainer to eliminate all debris, followed by hypotonic lysis with ice cold 
deionized water to remove the red blood cells19,53,57. Wound macrophages (CD11b+) were obtained from day 3/
day 7 wound cell infiltrate by magnetic bead based sorting as previously described19,53.
Immunostaining and flow cytometry. Markers used to determine monocyte and/or macrophage 
subsets comprised: FITC-F4/80 (Serotec) and PE-CD16/32, PE-CD11c, PE-CD40, PE-CD284, PE-CD206, 
PE-CD23(eBioscience). The cells were stained with surface markers and recorded using BD Accuri flow cytome-
try (BD Biosciences) and analyzed as previously described17,30,58,59.
Cell culture, differentiation, and treatment. The human THP-1 monocytic cell-line was cultured and 
differentiated to macrophages using PMA treatment as previously described18,57. The macrophages were treated 
with MCG as described previously16.
Figure 6. Proposed mechanism of action of Modified Collagen Gel-induced resolution of inflammation.
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RNA extraction, reverse transcription and quantitative real time-PCR (qRT-PCR). Total RNA 
was isolated from the cells using the mirVana RNA Isolation Kit (Ambion, Austin, TX), according the manufac-
turer’s directions as previously described15,16,18,19,53,57. miRNA expression was determined using specific Taqman 
assays and miRNA RT Kit (Applied Biosystems, Foster City, CA)15,16,18,19,53,57,60.
Enzyme-linked immunosorbent assay (ELISA). For the assay, wound cells or wound mφ (isolated from 
subcutaneously implanted PVA sponges) or THP-1 cells were seeded in 24-well plates cells (equally seeded for 
control and treatment). Cytokine levels were measured from commercially available ELISA kits as previously des
cribed12,18,19,30,53,57 and are expressed as per million cells.
Apoptotic cell clearance (efferocytosis) assay. Mouse macrophages that infiltrated PVA sponges were 
isolated as previously described19,53 and seeded into 8-chambered slides. Apoptosis was induced in mouse thymo-
cytes and the apoptotic cells were used to perform the efferocytosis assay as previously described19,53.
THP-1 cells with stable knockdown of miR-21. Stable knockdown of miR-21 was achieved in THP-1 
cells using lenti-miR-000-zip (control) or lenti-miR-21-zip vectors and puromycin selection as previously 
described18 followed by treatment with PMA to differentiate into macrophages18,57.
miRIDIAN miR mimic and small interfering RNA delivery. Delivery of miRNA mimic and small 
interfering (si) RNA were be performed as previously described18,61.
Immunocytochemistry and imaging. Cytospin smears from THP-1 cells suspension were fixed in cell 
fixation buffer (BD Cytofix, BD Biosciences, CA) for 10 min. Following fixation, cells were washed, blocked in 
10% normal goat serum (NGS) for 30 min and were incubated in primary antibodies for cJun (1:100; Abcam). 
Fluorescence tagged secondary antibody detection was performed with Alexa Fluor 488 secondary antibody 
(1:200, Life Technologies) as described previously30. Fluorescent images were collected using collected using con-
focal microscopy (LSM880). Image analysis was performed using Zen (Zeiss) software to quantitate fluorescence 
intensity.
Statistical analysis. Data are reported as mean ± SEM of 3–6 experiments as shown in the figure legends. 
Student’s t-test (two-tailed) and ANOVA were applied to determine the significance. p < 0.05 was considered to 
be statistically significant.
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